[Federal Register Volume 78, Number 39 (Wednesday, February 27, 2013)]
[Notices]
[Pages 13348-13349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-04535]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0001]


Science Board to the Food and Drug Administration Advisory 
Committee; Amendment of Notice

AGENCY:  Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Science Board to the Food and Drug 
Administration. This meeting was announced in the Federal Register of 
January 30, 2013 (78 FR 6332). The amendment is being made to reflect 
changes in the Date and Time, Agenda, and Procedures portions of the 
document. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Martha Monser, Office of the Chief 
Scientist, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 32, rm. 4286, Silver Spring, MD 20993, 301-796-4627, or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington DC area). Please call the Information Line for up-to-
date information on this meeting.

[[Page 13349]]


SUPPLEMENTARY INFORMATION:  In the Federal Register of January 30, 
2013, FDA announced that a meeting of the Science Board to the Food and 
Drug Administration would be held on February 27, 2013.
    1. On page 6332, in the third column, the Date and Time portion of 
the document is changed to read as follows:
    Date and Time: The meeting will be held on Wednesday, February 27, 
2013, from approximately 8:30 a.m. to 3:45 p.m.
    2. On page 6333, in the first column, the Agenda portion of the 
document is changed to read as follows:
    Agenda: On February 27, 2013, the Science Board will be provided 
with updates and/or a draft report from the Center for Devices and 
Radiological Health Research Review subcommittee and the Global Health 
subcommittee. Progress updates will be presented regarding the Global 
Health subcommittee and the recently established Center for Biologics 
Evaluation and Research Review Postmarketing Safety Review 
subcommittee. Overviews of genomics activities at the Centers for Food 
Safety and Applied Nutrition and Veterinary Medicine will be presented, 
along with plans for an Agencywide working group to address 
crosscutting genomics activities. Finally, recipients of the fiscal 
year 2012 Scientific Achievement Awards (selected by the Science Board) 
will provide overviews of the activities for which the awards were 
given.
    3. On page 6333, in the second column, in the Procedures section, 
the third sentence is changed to read as follows:
    Procedures: Oral presentations from the public will be scheduled 
between approximately 3 p.m. and 3:30 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: February 20, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2013-04535 Filed 2-26-13; 8:45 am]
BILLING CODE 4160-01-P